Essex of Columbia, MD, has announced a one-year extension of its partnership with the University of Maryland School of Medicine to continue developing the ImSyn optoelectronic image processor for advanced MRI techniques.By using laser optics with
Essex of Columbia, MD, has announced a one-year extension of its partnership with the University of Maryland School of Medicine to continue developing the ImSyn optoelectronic image processor for advanced MRI techniques.
By using laser optics with high-speed digital electronics, the company believes ImSyn could provide video-rate imaging without the use of supercomputers. Essex believes ImSyn could accelerate research and, eventually, clinical use of functional brain mapping, tumor ablation techniques for the breast and brain, and intraoperative image-guided surgery. Essex also plans to use ImSyn in microscopy and radar image processing applications.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.